Los Angeles Capital Management LLC increased its stake in shares of Genpact Limited (NYSE:G - Free Report) by 5.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 529,472 shares of the business services provider's stock after purchasing an additional 25,033 shares during the quarter. Los Angeles Capital Management LLC owned approximately 0.30% of Genpact worth $22,741,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in G. SRH Advisors LLC acquired a new position in Genpact in the 4th quarter valued at approximately $26,000. Manchester Capital Management LLC acquired a new position in Genpact in the 4th quarter valued at approximately $38,000. UMB Bank n.a. increased its position in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after buying an additional 433 shares during the period. Venturi Wealth Management LLC increased its position in shares of Genpact by 74.6% during the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock worth $103,000 after buying an additional 1,121 shares during the period. Finally, Versant Capital Management Inc increased its position in shares of Genpact by 17.0% during the fourth quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider's stock worth $136,000 after buying an additional 461 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Stock Up 1.0 %
NYSE G traded up $0.52 on Friday, hitting $53.22. 2,318,410 shares of the company were exchanged, compared to its average volume of 1,559,439. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a market cap of $9.39 billion, a PE ratio of 18.74, a PEG ratio of 1.84 and a beta of 1.20. The stock has a fifty day moving average of $48.00 and a 200-day moving average of $43.38. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.
Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.28%. This is a positive change from Genpact's previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. Genpact's dividend payout ratio (DPR) is 23.94%.
Insider Buying and Selling at Genpact
In related news, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the transaction, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the firm's stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.80% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on G shares. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC increased their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research report on Friday, February 7th. Robert W. Baird increased their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a research report on Friday, November 8th. Finally, Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $48.44.
Get Our Latest Report on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report